Small Molecules Capability

Australia is ideally positioned to be a major player in the global Pharma ecosystem where risk-averse companies are looking to in-licence assets that have demonstrated development potential.

Therefore, to enhance the progression of early stage discoveries through to preclinical development, TIA has formed a Small Molecules capability which is an integrated capability network of National Research Infrastructure across Australia. These facilities are committed to provide high quality research infrastructure to support leading‑edge research and to boost innovation in Australia.

Capabilities/Services offered  >

Compounds Australia


Pipeline Accelerator

Voucher scheme to support access to TIA facilities
Capabilities/Services offered  >

Australian Translational Medicinal Chemistry Facility 

ATMCF_latest logo_Dec 2020.png
Capabilities/Services offered  >

Centre for Drug Candidate Optimisation

Capabilities/Services offered  >

Centre for Integrated Preclinical Drug Development

Capabilities/Services offered  >



Contact us

+61 (07) 3735 4433


Subscribe to our newsletter to stay up-to-date on the latest news and events